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As of February 2021, the Food and
Drug Administration (FDA) has
authorized three COVID-19 vaccines
for emergency use. Data show that
these vaccines are extremely safe
and effective at reducing the severity
of COVID-19. Healthcare workers
(HCW)—including doctors, nurses,
trainees, and nonclinical essential
workers—were prioritized for vaccine distribution because of the
occupational risk they bear in fighting the pandemic. Although the supply of vaccines is still limited, many
HCW have already been vaccinated.
However, some HCW have declined
COVID-19 vaccination. Even before
COVID, HCW were among the most

hesitant populations towards occupational vaccines, such as the seasonal
influenza vaccine. Insufficient knowledge and understanding of vaccines,
including concerns about side effects
and doubts about effectiveness, are
cited as reasons for hesitancy among
HCW. (Loulergue et al., 2009) However, vaccine hesitancy among HCW
is a matter of public health because
HCW are disproportionately exposed
to immunocompromised patients, the
elderly, and children in their workplace and therefore have a higher risk
of transmitting or contracting communicable diseases. HCW are also
key connectors of information for the
public and have been shown to sway
patients’ vaccination behavior.
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In response to this hesitancy towards the COVID-19 vaccine,
many hospitals and other healthcare organizations are considering
whether to mandate or require
COVID-19 vaccinations for their
employees. Employer-based mandates should be assessed both
legally and ethically.
There are significant ethical and
legal concerns about mandating a
vaccine that is still under an Emergency Use Authorization (EUA).
The EUA statute does not specifically prevent employers from
mandating vaccines that have only
EUA status. (21 U.S.C. § 360bbb3.) However, under the EUA statute, certain conditions must be met
before a vaccine is administered.
Those who receive the vaccine
must be informed that it has been
authorized for emergency use, and
the “known and potential” benefits and risks must be explained.
Moreover, those receiving the
vaccine must be informed that they
have “the option to accept or refuse
administration,” as well as of “the
consequences, if any, of refusing
administration.”
There is uncertainty about whether
“consequences” of refusing vaccination may include adverse employment actions, including termination or reassignment. However,
in the context of the statute, it is
likely that “consequences” refers
to health-related consequences
only, and that all persons to whom
the vaccine is administered must
be given the “option to accept or
refuse” without threat of repercussions. On the other hand, the statutory requirements likely apply only
to the entity that actually administers the EUA vaccine, which may

not be the employer. If an employer
requires its employees to get the
COVID vaccine from a third
party—e.g., from a city or county
vaccination site—then presumably
the employer would not be subject
to the statutory requirements.
Nevertheless, the spirit of the EUA
statute suggests a commitment to
voluntariness that militates against
an employer vaccine mandate prior
to the FDA’s full approval of the
vaccine. After all, some COVID-19
vaccines that are currently available are the first to utilize the new
mRNA-based technology. So long
as there remains significant uncertainty about the risks of the vaccines, mandates seem difficult to
justify.
It is likely that some COVID-19
vaccines will soon be granted a
full Biologics License Application
(BLA) approval by the FDA. Current federal law generally allows
employers to mandate vaccines
as a condition of employment, so
long as they comply with laws
prohibiting employment discrimination. (Rothstein, Parmet, and
Reiss 2021) Ethical considerations
suggest that employers allow broad
accommodations for people with
medical, religious, and perhaps
even moral concerns, even if they
are not always legally required to
do so.
The Americans with Disabilities
Act (ADA) requires that employers
provide reasonable accommodation
to an employee or job applicant
with a disability, unless doing so
would pose an “undue hardship”
i.e., a significant difficulty or expense for the employer. Under the
ADA, a “disability” is defined as “a

physical or mental condition that
substantially limits a major life
activity.” (42 U.S.C. § 12102(2)
(A)-(C).)
Courts have generally been skeptical that a vaccine allergy is a
disability under the ADA. For
example, a federal district court
in Maryland denied an ADA
claim brought by a medical assistant who had a known allergy
to a component of the flu vaccine,
and who requested, but was not
granted, an exemption from the
vaccine mandate imposed by her
employer, a major medical center. (Eubanks v. Mercy Med. Ctr.,
Inc. (D. Md. Dec. 17, 2015).) The
court did not accept the plaintiff’s
argument that “the functions of
[her] immune system” constituted
a “major life activity,” and determined that her allergies did not
qualify as a disability under the
ADA. The court rejected the plaintiff’s claim under Maryland’s Fair
Employment Practices Act (FEPA)
on the same grounds. (Md. Code
Ann., State Gov't § 20-601(b)(1).)
This example suggests that the
conceptual framework of the ADA
is not well suited to vaccination
policies. The mere risk of suffering a vaccine-related injury, no
matter how great the risk or severe
the injury, does not itself impair a
major life activity. Such impairment typically occurs only after
the vaccine has been administered
and the injury suffered, but then
an exemption is of no avail. As an
ethical matter, therefore, employers ought not rely solely on the
requirements of the ADA, but
should craft a medical exemptions
policy that allows for exemptions
even when the underlying medical

condition would not qualify as a
“disability” under the ADA.
Title VII of the Civil Rights Act
of 1964 prohibits employers from
discriminating against employees on the basis of their religious
beliefs or practices, and requires
employers to accommodate these
beliefs and practices so long as
the accommodation does not
impose an “undue hardship, i.e.,
something 'more than a minimal
burden’ on the operation of the
employer’s business.” (29 CFR §
1605.2.) For example, offering to
transfer an employee who objects
to vaccines on religious grounds
to a different organizational role is
likely a sufficient accommodation,
even if the employee is unhappy
with this change.
The Equal Employment Opportunity Commission (EEOC), which
administers Title VII, defines
“religion” very broadly to include
beliefs and practices that are not
part of a traditional church or sect.
However, the category of religious
belief does not include personal
preferences, political views, or
beliefs about science or medicine.
For example, the belief that vaccines “may do more harm than
good” is a medical, not a religious belief. The EEOC definition
correctly reflects the important
autonomy interest that individuals
have in being able to live according to their sincerely held religious
or non-religious moral beliefs.
Finally, healthcare organizations
should consider the disproportionate impact that a vaccine mandate
may have on HCW who are members of a minority racial or ethnic
group. Data suggest that Black

Americans are much less likely
to trust the healthcare system and
express willingness to get vaccinated against COVID-19. (Egede
and Walker, 2020) Much of this
distrust of Black Americans in
medicine is rooted in a history of
oppression, exclusion, and exploitation evidenced throughout U.S.
history, and specifically within
American medicine. (Jones, 2021)
For this reason, imposing a vaccine mandate on HCW could
disproportionately affect Black
HCW, a group that is already underrepresented among doctors, and
in some contexts overrepresented
among non-clinical essential staff,
such as janitors and culinary staff,
who are likely to be much lower
paid and perceived by managers
as easier to replace. (Gaynor and
Wilson, 2020)
Moreover, if members of racial
minority groups disproportionately
refuse to comply with a strict vaccine mandate, and suffer adverse
employment consequences as
a result, their employer may be
liable for race discrimination
under Title VII. In particular, an
employer’s policy that results
in a disproportionate number of
adverse employment outcomes
for members of a certain racial or
ethnic group raises a question of
disparate impact discrimination,
even if the policy is race-neutral
on its face. (Cf. Griggs v. Duke
Power Co., 401 U.S. 42 4, 91 S.
Ct. 849 (1971).)
A mandate that disproportionately
impacts Black Americans and
other minority and underrepresented populations is ethically problematic whether or not it succeeds
Mid-Atlantic Ethics Committee Newsletter 3

in encouraging greater vaccine uptake. If it does succeed, the success could be tainted by the same race-based
coercion, paternalism, and exploitation that has long haunted American medicine. If HCW from minority groups
choose to refuse vaccination, however, and disproportionately lose their jobs as a result, then the mandate problematically contributes to unjust inequities in employment opportunity.
In conclusion, vaccine hesitancy raises the question of how best to promote COVID-19 vaccine uptake among
HCW. Strict mandates, however, without adequate opportunities to opt-out, are difficult to justify. Vaccine
mandates ought always to be considered a “last resort” intervention when combatting low vaccine uptake rates,
and should be carefully evaluated before implementation. Employer mandates face an even greater justificatory
hurdle than government mandates, as they are less effective at promoting public health goals such as herd immunity.
When considering vaccine mandates, employers must consult the law, but they should not assume that whatever
is not legally forbidden is therefore ethically permitted. Existing legal constraints sometimes inadequately reflect
the ethical considerations that apply to employer vaccine policies. (Parmet, 2018) Before imposing a mandate,
employers should consider alternatives such as masking, testing, and discouraging “presenteeism,” i.e., coming to work while ill. (Edmond, 2019) Employers should also seek to build voluntary buy-in and understanding,
particularly in light of equity concerns, through clear communication and honest engagement with all members
of the workplace community. The safest course, both ethically and legally, is to protect patients and workers
and effectively reduce workplace transmission through all means possible before considering and implementing
mandates.
Brian Hutler, JD, PhD and Rachel Gur-Arie, PhD
Hecht-Levi Postdoctoral Fellows
Berman Institute of Bioethics
Johns Hopkins University
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A Conversation about Vaccine Mandates:
MHECN COVID-19 Working Group
Early in the COVID-19 pandemic, MHECN established a COVID-19 Working Group to provide a forum for ethics
committee members from healthcare institutions around the state to share information about their experiences,
challenges, and solutions to problems they have encountered during the pandemic. Topics for discussion have
included allocation of scarce medical resources including ventilators, PPE, staff, and treatments such as remdesivir,
visitor policies, staff burn-out, allocation of vaccines, and most recently hospital vaccine mandates. In this article
we share a summary of the Working Group’s conversation on vaccine mandates.

COVID VACCINE MANDATES
Working Group’s (WG’s) thoughts
on the following questions:

An infectious disease physician
at a Montgomery County hospital
introduced the topic of whether
it is ethically justified to mandate
COVID vaccines for healthcare
staff after the vaccines are FDAapproved. At his hospital there
has been ~70% staff vaccine acceptance. Patients have already
asked if staff caring for them have
been vaccinated for COVID and
if not, some have requested to be
transferred to the care of another
provider. One can foresee hospitals advertising based on employee
vaccination rates, making this a
marketing tool, not just a public
health measure. He asked for the

Does information regarding vaccine refusal/acceptance pose a
breach of privacy/confidentiality?
There is a question of whether
information about employees’
COVID-19 vaccination status is
maintained on behalf of the employee health plan and thus covered by HIPAA’s privacy requirements. Even if this were true, a
waiver could be issued by the
employee.
Are vaccine mandates more effective than persuasion or incentives
(e.g., paid sick leave)?
The WG discussed concerns about
the efficacy of a vaccine mandate.
For example, it was suggested that
flu vaccine mandates for healthcare facility staff have not been
shown to produce the expected
outcomes of reducing patient
morbidity/mortality. Taking into
account that we do not currently
know to what extent COVID
vaccination itself reduces transmission, this may be relevant (a
presumed benefit of a vaccinated
worker is that he/she is less likely

to infect patients/visitors). In addition, a mandate could disincentivize employers from engaging with
staff to hear their perspectives and
earn their trust, which could widen
gaps in trust that are essential for
public health goals to be achieved.
Do vaccine mandates discriminate
disproportionately against marginalized communities?
Given that there are higher rates of
vaccine refusal among communities of color, and persons of color
are overrepresented in certain
healthcare sectors (e.g., long-term
care and ancillary hospital staffing), a mandate could disproportionately affect this already marginalized population by restricting
job opportunities for those who
prefer to avoid vaccination.
Is there a difference between
mandating vaccination for current
staff versus new hires?
Given that newly hired staff could
be told about the vaccine mandate and choose not to take the
job, some may see a difference
between mandating the vaccine
for current staff versus new staff,
since the latter would have
Mid-Atlantic Ethics Committee Newsletter 5

received “notice.” However,
whether one is deprived of getting
a job or of losing a current job
may not be an appreciable distinction.
Is reduced employee absenteeism
a sufficient reason for a mandate?
Even if vaccinating staff doesn’t
reduce patient contagion, there
is clearly a benefit in reducing
employee absenteeism due to
sickness. Reduced transmission is
also likely (though not yet demonstrated), and preventing hospitalizations and serious illness of
healthcare workers and those who
are immunocompromised (e.g.,
bone marrow transplant patients,
NICU babies) is an appreciable
benefit, as gaps in COVID protection can be fatal.
Are there valid contraindications
to COVID vaccine?
One physician reported that at his
hospital, for flu vaccine, which
is mandated for staff unless a
request is made based on health
exemptions, about 1% of staff
have a valid contraindication. This
is expected to be quite rare for
COVID vaccine. Anaphylaxis is
very low. A lawyer-ethicist offered
that the only appreciable risk at
the population level (for staff) is
dignitary and emotional, that is,
taking away a worker’s choice to
refuse the vaccine (for whatever
reason). They get the benefit of
being spared from serious illness/
death, protection from symptomatic illness, and most likely not
being a vector within their own
household.
Is a COVID vaccine mandate ethically justified?
The consensus of the group is that
there is more benefit from ensur6 Mid-Atlantic Ethics Committee Newsletter

ing that all staff are vaccinated
and although the answer to “can a
vaccine mandate be implemented”
is “yes,” the question of “should a
vaccine mandate be implemented”
needs to be considered from all
angles. It is comparable to the
flu vaccine mandate. Is there an
opt-out for anyone? Will staff
declining vaccination be stigmatized? Isn’t it ethically preferable
to engage staff and try to get their
buy-in?
A hospital chaplain noted that we
all live in a community, and there
are inevitable conflicts between
respect for autonomy and promoting the common good; there are
times autonomy can be justifiably
overridden. While the harm is not
trivial, it can be reduced if people
feel like they have been heard/
respected enough for that conversation to be had by them or people
who look like them. Of note,
no religious body has come out
against COVID vaccines.

whether, even when supply is
adequate, we will reach herd immunity. Healthcare is one of the
few sectors that will be put out in
front of this to make this decision.
Which groups will be mandated to
get vaccinated? Teachers, healthcare workers, airline employees
(i.e., those in unavoidable close
proximity to those they serve)?
A physician echoed the need to
have conversations at the C-suite
level to achieve procedural justice,
and to include diverse representation in these conversations. She
underscored that how administrators do this matters; a mandate
may be OK but that doesn’t
absolve leaders from talking with
rather than at employees.
A law professor suggested that
the word “mandate” is negatively
laden and might be replaced with
another term. However, another
lawyer in the group warned of the
dangers of euphemisms, and that
honesty is important.
A physician mentioned that her
hospital was reluctant to impose vaccination with the threat
of termination. However, many
companies and healthcare facilities appear to be moving toward
mandates.

An emergency planning expert
noted that in previous epidemics
(e.g., Ebola, HIV/AIDS) there
were similar concerns; everyone
has an opinion (s)he should not
be afraid to voice. Leadership has
learned they need to gather those
opinions to form a marketing
campaign to support their decisions. Based on what we know so
far, there will be a lot of people
refusing a vaccine. It is not clear

The WG agreed vaccination must
be part of a multi-prong strategy,
and that a variety of individuals
should be at the table when deciding whether it should be mandatory, from janitors and kitchen
workers to nurses and physicians.

COVID-19 Vaccine Ethics Forum Focuses on
Interprofessionalism, Equity, and Faith
On November 10, 2020, MHECN
co-sponsored the Seventh Annual
Interprofessional Forum on
Ethics and Religion in Health
Care: Unraveling Vaccine Science,
Faith, and Public Discourse. Vaccine researcher and University of
Maryland (UMB) School of Medicine faculty Dr. Matthew Laurens
gave an overview of COVID-19
vaccines being tested in clinical
trials.
Deanna Tran, with the UMB
School of Pharmacy, reviewed
causes of “vaccine hesitancy,”
mostly resulting from misinformation and myths, for example,
that vaccines cause autism or
overload the body’s immune
defenses (science has debunked
both positions). Dr. Tran called
for a multidisciplinary approach
to overcome vaccine hesitancy by
role modeling vaccine adoption
and using motivational interviewing techniques and outreach efforts
to educate patients and the public
about vaccine efficacy and safety.
Trudy Henson, Public Health
Program Director at the Center
for Health and Homeland Security
and an adjunct professor at UMB’s
Carey School of Law, reviewed
the law and policy considerations
for COVID-19 vaccines that
become available, such as how
to fairly allocate vaccines that
are in short supply, and whether
mandating vaccination would be
justified or effective. She provided
background information on existing public health powers, such

as those articulated in the 1905
Supreme Court case Jacobson v.
Massachusetts, while emphasizing that vaccine mandates might
not be the only or most effective
policy approach. While highlighting the importance of promoting
vaccination through encouragement and example, Henson also
spoke on the potential pitfalls
of strongly encouraging or even
mandating vaccinations should
demand exceed supply, which
occurred with the H1N1 vaccine
in 2009. Responding to questions
after her presentation, she also
discussed the likelihood of vaccination becoming a condition of
employment for some frontline
healthcare workers, explaining
that while such requirements were
likely to be permissible, especially
for private employers, those mandates were likely to be delayed
due to questions of supply.

Yolonda Wilson, Fellow with
the National Humanities Center
and Encore Public Voices, addressed how systemic racism has
harmed—and continues to harm—
Black and Brown people by way
of their being more susceptible to
suffering serious and fatal

COVID-19 disease and having poorer access to COVID-19
research, testing, treatment, and
vaccination opportunities. For
example, researchers may simply
assume that Black people don’t
trust science and won’t volunteer
for research trials, rather than
enlisting their feedback about how
to gain their trust and cooperation.
Ken Berkowitz, Special Advisor
with the Veterans Health Administration’s National Center for
Ethics in Health Care, reviewed
data showing that healthcare facility flu vaccine mandates for staff
have not achieved better outcomes
compared to voluntary flu vaccination. Given that vaccination rates
are lower among persons of color,
this raises the question of whether
vaccine mandates unfairly disadvantage persons of color. Individual liberty should be preserved if
persuasion can effectively promote
trust that vaccines are in an individual’s best interest and that of
their community.
Rabbi Shmuel Silber of Suburban
Orthodox Toras Chaim offered a
Jewish interpretation of the tension between faith and science.
God has control over everything –
both the pandemic and the science
that creates remedies to cure and
eradicate disease. When there is
tension between the needs of the
community and the individual, the
community always wins out. This
is a view focused on individual
responsibilities to create a society
that benefits every individual. If
a vaccine is found to be safe and
Mid-Atlantic Ethics Committee Newsletter 7

effective, there is an obligation to
take the vaccine. The overwhelming majority in the Jewish community are “pro-vaccine” for this
reason. A Jewish approach to vaccine allocation would use a similar
calculus to identify what is best
for the community (for example,
prioritizing frontline healthcare
workers who are in the greatest
danger and who can preserve others’ well-being).
Bowyer Freeman, Senior Pastor
at New St. Mark Baptist Church,

proposed that science and religion
work together to help us better
understand our human nature.
Pastor Freeman’s background
in genomics gives him a unique
perspective on this issue. For example, new genetic advances may
benefit some and exacerbate social
disparities for others. In order for
COVID-19 vaccine science to
benefit all, it must be adopted by
the majority to achieve the goal
of herd immunity. Trust is key. Indeed, pastoral care, clinical ethics,
and medicine require a foundation

of trust. Pastor Freeman referred
to this as “trust economics,” a
term not intuitively aligned with
religion. However, considering
that “economics” involves the
production, consumption, and
transfer of wealth, a spirituallyinformed approach recognizes that
wealth and health are intertwined,
and that when large portions of
the community are left behind,
societal wealth is elusive. This is
something we have seen first-hand
during the COVID-19 pandemic.

Anita J. Tarzian, PhD, RN
MHECN Program Advisor

The recording and slides of the November 10 forum are available on MHECN’s website,
under Workshops and Conferences.
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Allocating Scarce Medical Resources at Hospitals in Maryland

In response to the COVID-19
pandemic and the possibility of resource shortages, Maryland’s five
largest health systems (The Johns
Hopkins Health System, the University of Maryland Medical System, MedStar Health, LifeBridge
Health, and Luminis Health)
partnered to develop guidelines
and processes for the allocation
of scarce resources (ASR). These
five hospital systems, or the “5H,”
engaged with multi-disciplinary
working groups to recommend
a series of factors that should be
considered in deciding who should
receive scarce resources during a
pandemic such as COVID-19. The
resulting draft framework, published as “Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis”
and referred to herein as the 5H
ASR Framework, seeks to enhance
survival and maximize treatment
benefits for as many patients as
possible when resources are scarce
while prioritizing ethical considerations. The 5H ASR Framework
includes triage plans for eight
scarce resources: ventilators, blood

products, ICU beds, ECMO, dialysis, convalescent plasma, remdesivir, and hydroxychloroquine.
Acknowledging that the
COVID-19 pandemic is not over
and that future pandemics are
possible, the Maryland Healthcare Ethics Committee Network
(MHECN) has worked with
representatives of the five healthcare systems to make the 5H ASR
Framework available to Maryland
hospitals and the public. The purpose of dissemination is to make
the community aware of choices
that would be made by hospitals
if these medical resources were in
short supply.
In February 2021, MHECN’s
COVID-19 Working Group collected feedback on the 5H ASR
Framework from MHECN members (including healthcare ethics
committee members) and contacts
through its listserv and encouraged
broader dissemination. MHECN
received twenty-one responses,
reflecting a wide variety of healthcare professions including physi-

cians, clinical ethicists, social
workers, and palliative care providers. Approximately eighty percent of respondents were familiar
with ASR frameworks, nationally,
for pandemic triage during crisis
situations. However, respondents
were far less familiar with the 5H
ASR Framework and the 2017
proposed ASR framework which
the current 5H ASR draft is based
on. Of the scarce resources included in the 5H ASR Framework and
in the survey, survey respondents
had the highest familiarity with
ventilator allocation. The high
familiarity with ventilator triage
plans was expected since mechanical ventilators were identified as
a possible scarce resource early in
the pandemic.
Since the 5H ASR Framework
is based on distributive justice
with equitable and standardized
practices, fairness in triage decisions is critical. When asked
which components of the 5H ASR
Framework are the most critical
for ensuring fairness in ASR triage
decisions, respondents identified
the availability of palliative care
and hospice services for patients
not eligible for limited lifesaving resources as a top concern.
Respondents also indicated the
importance of clear communication between healthcare providers
and patients and their families
about the ASR process. Another
primary concern was avoiding
biased decision-making based on
age, race, or disability.
Looking towards implementation,
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respondents were somewhat confident that limited life-saving resource decisions would be fair if Maryland
hospitals use the 5H ASR Framework during the pandemic under crisis standards of care. Although respondents
appeared optimistic, there were underlying concerns that decisions would still be biased even if the 5H ASR
Framework is followed. One respondent stated that “there may be clinicians who figure out how to bypass the
framework.” Another stated that “[m]ost people will try to do their best to be fair, [but] there will be some problems in achieving this completely.” Respondents expressed concerns about the successful implementation of the
framework in the chaotic emergency room setting where there may not be sufficient time for review, stating that
“[t]he use of a framework will be very important to avoid ad hoc decision making, which is known to be more
biased.”
Numerous comments addressed the need for a clear anti-discrimination statement in the draft to emphasize
that allocation decisions should not be based on age, disability or quality of life and life-cycle concerns. One
respondent commented that “decisions should be made on objective, evidence-based predictions on survival to
discharge and no decisions should be made based on the patient’s perceived quality of life.” Apprehension that
people with disabilities may be disfavored under the framework has been a longstanding point of concern for
various stakeholders, as even neutral language meant to avoid discrimination can produce disparate outcomes.
MHECN’s Working Group believes it is important to continue public engagement and incorporate stakeholder
concerns as the 5H ASR Framework circulates among Maryland hospitals. The MHECN survey provided elucidating insights into the health community’s familiarity and views of the 5H ASR Framework. MHECN hopes to
continue to seek out stakeholder input and concerns from the general public. It would be useful to better understand the public’s familiarity and perspectives on resource allocation for both community input and transparency in potentially difficult resource allocation decisions. No ASR framework will be perfect, but MHECN seeks
to provide feedback to the 5H drafters that includes different perspectives and responds to community priorities
to further ethical principles of justice, transparency, participation, and accountability.
The proposed ASR framework and related documents are available on MHECN’s website.
Stephanie Vangellow, MPH and
Rob Stenzel, MBE
JD Candidates
University of Maryland
Francis King Carey School of Law
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others
in the case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to
identify the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be
sent to MHECN@law.umaryland.edu.

CASE STUDY FROM A MARYLAND HOSPITAL
Baby L, an infant of about 24
weeks gestation, is delivered
precipitously en route from the
emergency room to the Labor and
Delivery suite. The infant has poor
respiratory effort and is bradycardic to 60 bpm. She is stimulated
and mask-bagged. She is intubated
shortly after birth and transferred
to the NICU after being briefly
shown to her mother.
The father is called and immediately came to the hospital to
see his newborn infant. Updates
are provided to the mother who
remains in the Labor and Delivery
suite.
The parents are both devout Jehovah’s Witnesses. Because of their
faith, they are adamant that Baby
L not receive any blood products.
The mom tells one nurse: “If you
give her blood, I will not take her
home with me.”

Although most of the mother’s
family lives in Africa, she has
strong social support from other
family members who live nearby.
A patient advocate affiliated with
the Jehovah’s Witness community
also provides support for the mom
at the hospital.
At 24 hours of age, the infant
remains critically ill but fairly
stable. She is active and alert, her
labs are not suggestive of infection, her perfusion and color are
good, but she remains on respiratory support. The staff remain
cautiously optimistic about the

baby’s prospects. However, the
parents’ refusal of blood products
quickly becomes a worry, as staff
anticipate the clinical trajectory of
the infant and her associated need
for blood transfusions. Wanting
to draw upon every supportive
resource to help give the baby a
fighting chance, the baby’s primary nurse requests an ethics consult.
She, in collaboration with the
NICU team, wants to be proactive,
avoid last-minute scrambling, and
explore every conceivable remedy.
She wants to know if the healthcare team would be able to give
the infant a blood transfusion if
necessary to save her life or avoid
serious health problems.
How should the ethicist or ethics
committee respond?
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Comments from a Neonatologist/Bioethicist
Advances in neonatal medicine
continue to improve the survival
of infants with severe medical
conditions, including infants born
extremely premature. Yet the
morbidity and mortality related
to extreme prematurity are substantial in the United States and
similar countries with intensive neonatal care. Data from
the National Institute of Child
Health and Human Development
(NICHD) suggest that for infants
born at 24 weeks the average
survival is 50%. Among infants
who survive to 18 months of age,
one-third to one-half have moderate to severe neurodevelopmental
impairment. (1)
The infant in this case has several
additional risk factors. The gestational age seems uncertain (“about
24 weeks”) which is crucial; if for
instance her gestational age is really closer to 23 weeks, the average survival decreases to 30% and
as many as 80% of survivors have
moderate to severe neurodevelopmental impairment. (1) The cause
for premature labor in this case is
not disclosed to us, but one of the
most common triggers is infection. Infection will increase both
neonatal morbidity and mortality;
we are told the infant’s labs and
clinical status are reassuring for
no infection, but the infant was
just born 24 hours ago. Another
concern is that this infant was
presumably born outside the hospital with delayed admission to an
ICU. Rarely do Emergency Medical Technicians who respond to
911 calls have the equipment and
training needed to resuscitate an
extremely premature infant. The
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resulting hypothermia, inadequate
oxygenation and ventilation, hypotension and infection exposure all
increase morbidity and mortality.
(2) For example, we are told that
the initial infant heart rate was
~60, often a trigger for neonatal
CPR, but are not told if CPR was
performed.

of value to the infant, to avoid all
transfusions. Jehovah’s Witnesses
believe that the Bible forbids taking of blood and that those who do
will be shunned from the community and endanger their souls.
(8) The parents here indicate that
they will abandon the infant if she
receives a transfusion.

It is with the above factors in mind
that we must interpret the clinicians’ “cautious optimism” that
this infant will do well. Clinicians
are poor at determining prognosis
for individual premature infants.
(3) Key to this case are the odds of
anemia and severe thrombocytopenia. As many as 80% of premature infants get red cell transfusions. Their anemia results from
immature and impaired erythropoiesis and frequent blood draws,
in addition to the common complications of sepsis, bleeding, and
need for surgery. (4) Over 60%
of premature infants get platelet
transfusions for severe thrombocytopenia which, if untreated, can
lead to intracranial hemorrhage
and further neurologic insult. (5)

While adults generally have autonomy to make decisions about
refusing life-sustaining therapies
for themselves, parents cannot
always make similar decisions for
their children. Parent decisionmaking neither falls squarely
within the concept of autonomy
nor surrogate decision-making.
The principle of “best interests” is
often applied to parent decisionmaking for children, others use the
guidepost of “avoiding harm.” The
ethical and legal latitude given to
parents who refuse treatments for
a child often hinge on whether the
treatments are emergent. If emergent, the child’s interests generally
prevail, and physical/physiologic
interests are given greater value
than spiritual interests.

While the need for transfusion is
common in extremely premature
infants, there are data to suggest
that overzealous transfusion may
also be associated with intraventricular hemorrhage, necrotizing
enterocolitis, and retinopathy of
prematurity. (6) Ongoing research
is focused on determining optimal
thresholds for transfusions for
these infants. (7)

We are told that the medical team
is acting to avoid such an emergent situation, asking the ethics
consultants to assist with aligning
the parent and medical team goals.
Medically, there are several proactive approaches that may minimize
transfusion need. Clinicians can
pay meticulous attention to whether a lab needs to be drawn from
the infant, optimizing her blood
volume. There are data to suggest
that transfusion protocols may
reduce the use of blood products
by standardizing lab orders and

In this case, the religious beliefs of
the infant’s parents raise the question of whether it is possible, and

thresholds for responding to anemia. (9) Intravenous iron can be added. Studies of erythropoietin have mixed
results for extremely premature infants but could be considered, if the locally-available formulation is acceptable to the parents. There are fewer options to proactively manage severe thrombocytopenia. Treatment with
recombinant factors would be possible, though the limited data in this population raises concerns for unproven/
experimental therapy in a very vulnerable patient. Some medical centers have expertise in “bloodless” medicine
and surgery and could be consulted for additional strategies; again, relevant data is limited for extremely premature infants. The Jehovah’s Witness website offers other supports for clinicians seeking blood-conservation
strategies for Jehovah’s Witnesses.
These proactive medical strategies should be paired with proactive ethical and legal strategies. The team must
gather information about this particular family’s beliefs regarding specific blood products—not all Jehovah’s
Witnesses have exactly the same beliefs. It is unclear in the above case whether the parent(s) are also from another country; if so, the interplay of religious and cultural beliefs deserves exploration. It is important to explore
whether these parents believe that their religious culpability is averted if the clinicians actively override the parents’ wishes and transfuse the infant based on medical necessity. If this is consistent with with their beliefs, this,
in combination with meticulous efforts to minimize transfusion need, may be an agreeable common ground. The
family may need reassurances of confidentiality to minimize risk of censure by their community. Many hospitals
have a Jehovah’s Witness liaison to assist clinicians and families in these scenarios.
When common ground cannot be found, clinicians need to know whether their state has relevant legal cases/
statutes relevant to transfusion practices for Jehovah’s Witnesses, particularly for cases involving sick minors.
(10) Some states may allow physicians to override parent refusal of transfusion in emergencies; some may
protect physicians from liability if they accede to parent refusal of transfusion. Some hospitals may encourage
seeking a second opinion and then transfer to a center willing to follow the parents’ wishes. It should be noted
that the transfer of an extremely premature infant at 24 hours of age risks additional morbidity/mortality, so this
option for this infant would need to be considered very carefully.
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Comments from a Healthcare Attorney
We are presented with the case
of an infant of 24 weeks’ gestation. Her parents are described as
devout Jehovah’s Witnesses who
are opposed to blood transfusions.
Baby L is critically ill but fairly
stable after birth, and the ethics
committee has been asked by the
baby’s nurse to consult on the
baby’s care in order to avoid lastminute scrambling.
It is critical to note that, at “about”
24 weeks’ gestation, Baby L is in
the “periviable” window. Any
infant of 24 weeks’ gestation has
a number of critical care decisions that need to be made, of
which the transfusion issue is only
one aspect. Baby L is within the
window when a number of infants
do not survive or only survive but
with significant and permanent
limitations, even if they do receive
transfusions.
I would recommend that a social
worker first talk to the parents to
learn more about their values, priorities, religious beliefs, cultural
values, family or religious community pressure, and understanding of their daughter’s clinical
situation. The person meeting
with the parents should know that
Jehovah’s Witnesses are generally
supportive of modern medicine,
except for the transfusion issues.
The person should also be aware
that different Witnesses have differing interpretations of the prohibition on blood transfusions—for
example, some Witnesses allow
the transfusions of plasma but not
whole blood, while others prohibit
all blood products. Social workers are often better at interviewing patients than busy members
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of the care team, who can make
parents feel defensive or pushed,
sometimes causing them to become more adamant. If possible,
it could be helpful to interview
the parents separately to allow for
candid one-on-one communications, as sometimes one parent
may be afraid to state his or her
own views or to ask questions
in front of the other. During all
phases of the treatment process,
the parents should be provided
with the best available information
as to the baby’s clinical situation
so that they can make the most informed decisions about all aspects
of the baby’s care, not just those
pertaining to the transfusion issue.

The American College of Obstetricians and Gynecologists
(“ACOG”) published a position
paper in October 2017, called
the “Obstetric Care Consensus.”
The ACOG statement describes
periviable as 20–26 weeks and
notes that, while a number of factors can influence viability, it is a
very complex and ethically challenging area. It notes no “bright
line,” but, rather, gives a range of
outcomes based on various factors and analyses. The statement
notes that very small differences
in gestation can materially affect outcomes, i.e., if “about 24
weeks” is really closer to 23 or 25
weeks, the clinical outcomes can

vary significantly. After reviewing
various clinical issues, the ACOG
article discusses the importance
of family counseling, “giving the
patient [mother] and her family
the opportunity to express their
values and preferences.” The article talks about the importance of
interdisciplinary perspectives and
coordination to ensure consistent
messaging, including acknowledgement when data are uncertain
and consensus cannot be obtained.
“It is important that the healthcare
team provide accurate, balanced,
and unbiased information and
guidance.” (p. e195)
The ACOG statement also notes
that, because different providers may have differing views and
the treatment teams may vary or
rotate, “it is preferable that institutions develop consensus guidelines regarding counseling about
outcomes and a general approach
to resuscitation of the periviable
newborn... The family should be
counseled regarding short-term
and long-term consequences that
are anticipated in the context of
evolving clinical findings for their
newborn...When a decision has
been made to withhold or withdraw life-sustaining treatment
after birth, the newborn should
receive individualized compassionate care that is directed toward
providing warmth, minimizing
discomfort, and allowing the family to spend as much time with
their newborn as desired.”
The consistent theme in the ACOG
statement is that decisions regarding periviable newborns should
generally be made by the patient

and her family, giving them as
much support, information and
time as is reasonably available.
An article published in 2021 from
the aptly-named “UpToDate.com”
concurs, noting that “most infants”
survive over 26 weeks and few
survive below 22 weeks, so the
difficult range is 22-26 weeks.
They note the difficulty in precisely calculating gestational age
and the several factors that affect
survivability within the window.
While the statute relates to abortion rights, Md. Code Ann HealthGen. 20-209 uses a medical definition of viability—that of when the
attending physician finds, using
her best medical judgment based
on the particular case, that there is
a reasonable likelihood of survival
outside the womb.

Once the parents have been
interviewed in the most comfortable manner possible, they should
be invited to meet with the ethics committee (or ethicist) in a
non-confrontational forum for a
discussion as to how to best care
for Baby L. Given Baby L’s birth
within the window of periviability, the threshold question of
whether to provide aggressive or
comfort care should be addressed
first, aside from the transfusion
issue. If the decision is to provide
aggressive care, additional decisions need to be made, including a
discussion regarding transfusions.

Critical members of the treatment team should also be present so as to
provide important clinical information.
The meeting should seek to promote dialogue and to problem-solve,
rather than to push anyone’s agenda or to dissuade the parents from their
religious beliefs.
It is possible to obtain a court order to override the parents’ wishes as to
transfusion issues, and I have done so in appropriate occasions when an
infant would be otherwise viable and may be in need of a transfusion that
overrides a parents’ religious beliefs. Typically such orders name a hospital administrator as emergency guardian of the person with the limited
authority to be able to consent to transfusions, are obtained for very short
windows of time (144 hours), and are sought, whenever possible, with
appropriate advance notice to the parents and with counsel appointed for
the infant. They are often scheduled for a subsequent hearing after the
initial period has expired, but subsequent hearings are often moot. In
some cases, the administrator never has to consent to a transfusion, as
every reasonable effort is made to avoid the transfusion, both for clinical
reasons and due to the parents’ objections.
We do not know all the facts in this case that would be available in a
real situation. However, given that Baby L is reportedly in the midst of
the periviable period, I would counsel the hospital to try to defer to the
parents’ decision-making, based on as much objective information as
time and the patient’s situation will allow and a discussion of the parents’
beliefs and priorities, so long as the decisions are made within the boundaries of the law and Hospital policy.

Sigrid C. Haines
Partner
Whiteford, Taylor & Preston
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What the Ethicist and Ethics Committee Did

After a chart review, the ethics director’s first call was to legal and
then he proceeded to Labor and
Delivery to meet the mother. They
talked about the wonder of birth,
the challenges ahead, her love for
her infant, and how she wanted
everything done to save the life of
her baby; the one exception being
administering blood products. The
ethics director asked if she would
like a visit from one of the hospital
chaplains to provide spiritual support. After being assured that the
ministry would be provided in the
name of Jesus and Jehovah, she
gratefully agreed. The ethicist assured the mother that she and her
infant would receive the best care
possible and that he would remain
in regular contact. She smiled and
expressed her gratitude.
Meanwhile the hospital’s legal
and risk management offices were
examining what options might be
available. There was not an appetite for going to court to try to
get a judge’s emergency ruling to
allow the hospital to administer
blood products. They felt there
was not sufficient precedent in
the state of Maryland. Thus the
initial legal recommendation was
to invoke the emergency treatment
section of the Maryland Health
Care Decisions Act (MHCDA).
The attorney’s thinking was:
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1) The treatment would be of an
emergency nature; 2) The people
authorized to give consent would
not be immediately available; and,
3) Without the treatment there
would be substantial risk of death.
That approach, however, did not
resonate with the clinical care
team as the mom was still a patient
in Labor and Delivery and the
father was just a phone call away,
and it would take a bit of time to
actually get blood delivered to the
unit. Of course the parents were
available for decision-making. In
response, the ethicist reached out
to a law professor who was familiar with the MHCDA for a collegial discussion and opinion. She
recommended that we reconsider
going to court making the argument that it was an emergency as
the infant could decompensate at
any time. This opinion was relayed back to the hospital attorney
and he was asked to reconsider
his recommendation. When it
became apparent to legal counsel
that treating under the auspices of
the parents being unavailable to
provide consent was not a viable
approach, he agreed to explore
the option of going to court. Risk
management was going to explore
options as well, and the ethicist
was going to engage in another
conversation with the baby’s
mother, as they had established a
warm and trusting relationship.
Meanwhile, the staff continued to
worry as the infant remained in
critical condition and they knew
that the time was approaching
when blood transfusions would
be necessary. All involved were

caring for Baby L not just with
skill and determination, but with
kindness and concern.
During a lengthy conversation, the
baby’s mother once again affirmed
that blood products were not to be
used. She and the ethicist openly
discussed how seriously ill her beloved daughter was and that soon
the physicians would likely be at
a point where they would need to
provide blood in order to save the
life of the child. She was directly
asked what are we to do when that
point comes? She replied: “Well
that would be a decision that YOU
make.” A door seemed to be opening. Asked if she would accept
the doctors’ decisions, she said,
“Yes.” A preliminary conversation
then took place about allowing the
care team to become the medical
decision-maker regarding what
treatments would be necessary to
potentially save the life of Baby
L. Several follow-up discussions
were held throughout the morning and afternoon, and the mother
affirmed each time that she would
allow the medical providers to
make decisions about necessary
treatments. These discussions
were documented in the chart.
Next, the Patient Care Advisory
Committee (PCAC) process was
explained by the ethicist to the
mother and she accepted the invitation for herself and her husband
to attend the meeting. She was
informed who the participants
would be: COO as designee of the
hospital president, SW, physician
who is not the attending, director
of risk management, senior nurs-

ing director, chaplain, and ethics
director as moderator. She was informed that the recommendations
of this group would be implemented by the hospital. If she and
her husband disagreed they would
have the right to take the matter
to court and ask a judge to reverse
the decision or they could seek a
transfer of the patient.
The process began with a meeting between the care team and the
PCAC, the purpose of which was
to discuss the clinical details. The
consensus recommendation of the
PCAC was strong and clear: given
that Baby L was most likely to
need life-saving transfusions, there
was a medical necessity for the
care team to have that treatment
available to use. The PCAC would
present that decision to the family.
The PCAC meeting was held with
Baby L’s parents immediately
thereafter. Although this situation
was taking place during a time
when most meetings were being
held via Zoom, the PCAC felt that
face-to-face interaction was essential. After introductions, the medical situation was updated for the
family. They were again informed
about the baby’s anticipated need
for blood products.
The Committee members explained that they had reached a
consensus that blood products are
likely to become medically necessary in order to provide optimal
care for their baby. The parents
understood the situation and
indicated that they did not want to
contest either the decision or the
treatment plan. They proceeded to
explicitly ask that the clinical care
team become the decision-maker,
not just for blood-related decision-

making but for all treatments. Each stated they trusted that whatever
decisions were made would be in the best interests of Baby L. They indicated that all they were asking for at this point was to be kept informed
of what treatments were being provided and to receive regular updates on
how their daughter was doing.
When the outcome of the meeting was shared on the NICU the relief was
palpable among the staff. They were caring for the infant with dedication, skill, and tenderness, and with some emotional investment. In the
week to come, Baby L’s medical condition waxed and waned. For the
most part she remained in critical condition—on respiratory/temperature/
and feeding support, moderately increased heart size with apnea/bradycardia/desaturation episodes, and continuing anemia. That said, she also
remained reassuringly active.
Thirteen days after being born, however, Baby L developed hydrocephalus. Two days later she was transferred to a regional pediatric hospital
where she remains in critical but stable condition as of this writing. The
ethics notes, which describe the agreed-upon process for making decisions, especially in regard to blood products, accompanied her.

Comments from the Hospital’s Ethics
Director

with unwavering commitment,
acted on the moral obligation to be
a voice for the infant who could
not advocate for herself, respecting but giving less weight to the
autonomy of the parents in preference to the welfare of the baby.

The ethical dilemma is fairly
straightforward. There is obvious tension between respecting
the autonomy of the parents as
decision-makers and honoring
their firmly held religious beliefs
and protecting the welfare of a
vulnerable, critically-ill infant who
cannot speak for herself. The care
team, regularly assured the parents
that we would always respect their
faith but that our primary goal was
to give Baby L the best chance to
survive and be as healthy as possible. From very early on, the team,

In an ironic and parallel fashion
the parents were also working out
their own internal moral dilemma.
They had to grasp two opposing
pathways at once: live by their
faith and do the right thing for
their baby. These were not synchronistic courses of action. As
the parents were struggling to find
a way to reconcile the conflicting
options, they began to see how the
agreed-upon solution offered them
a way for bending but not breaking their faith while giving their
daughter the very best chance at
life. In never having been required
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to give consent for blood products they would be relieved of some shame and guilt, as well as moral culpability.
Recently, the Senior Nursing Director remarked, as we were discussing Baby L’s current condition at [the
pediatric hospital], “I hope after she is fully stabilized, she will come back to us. She will get great care at [the
pediatric facility]. Here she will receive great love.”
A few salient take-home lessons loom large:
• The all-hands-on-deck approach, which was activated early on, was helpful.
• Building trust across a cultural divide is essential. This requires time and being mindfully present at the
bedside.
• Being creative and relentless in considering options and approaches can be useful.
• Applied ethics entails rolling up one’s sleeves and engaging with all of the important stakeholders in
interdisciplinary collaboration. It extends far beyond philosophical and theoretical approaches to
resolving problems.
• Sometimes love works, even in the high-pressured environment of modern healthcare.
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CALENDAR OF EVENTS
2021 Webinar List

Children’s Mercy Kansas City
Brown Bag Workshops*
Use of Tertiary Care Pediatric Emergency Department for Over-the-Counter Medications
Tuesday April 27, 2021
Cassandra Newell, MSN, CPNP, RN, CPN, Pediatric Nurse Practitioner, Emergency Department, CMKC
LeChelle Nelson, RN, CPN, MSN, CPNP-BC, Critical Care Nurse Practitioner,
Emergency Department, CMKC
Rates of Positive Suicide Screens among the Emergency, Inpatient and Outpatient Clinics at a
Tertiary Care Children’s Hospital
Tuesday May 18, 2021
Fajar Raza, MBBS, Pediatric Ethics Fellow, CMKC
Shayla Sullivant, MD, Child & Adolescent Psychiatrist, CMKC
Do Reasons Matter? Rethinking Pediatric Treatment Disagreements
Tuesday June 22, 2021
Amy Caruso-Brown, MD, MSc, MSCS, Associate Professor of Pediatrics and Bioethics & Humanities,
SUNY Upstate Medical University, Syracuse, NY
*All Brown-Bag Workshops take place from Noon – 1PM CDT. For non-employees of Children's Mercy, please
contact Jeremy Garrett (jgarrett@cmh.edu) and Jennifer Pearl (jepearl@cmh.edu) via email (preferably at least 3
business days in advance) if interested in attending.

Pediatric Bioethics in the Shadow of COVID Symposium
Wednesday, May 5, 2021 9:00 am CDT

The COVID-19 pandemic raised complicated ethical issues for children and those who care for them. Children’s
Mercy Bioethics Center will host a symposium to discuss these complex ethical issues. Thought leaders in pediatric
bioethics and health policy will reflect on the successes, failures and surprises that arose and that likely will continue
with the COVID-19 pandemic. Register here.

Columbia University
Racing with Vaccines: Data, Narratives, and Ethics
With Robert Klitzman (Bioethics), Danielle Spencer (Narrative Medicine), and David Kreutter (Applied
Analytics). Watch the recording here.
COVID-19 Related Webinars compiled by the Columbia University Department of Medical Humanities
and Ethics can be found here.
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CALENDAR OF EVENTS (cont.)
Hastings Center
Hastings Center President Mildred Solomon was a featured speaker on Included: The Disability
Equity Podcast of the Johns Hopkins University Disability Health Research Center. Read the transcript
here.
Advancing Social Justice, Health Equity, and Community. The Daniel Callahan Annual Lecture, with Duke
professor Patrick Smith and Hastings Center president Mildred Solomon, was held February 9, 2021. Click
here to watch the Zoom event.

Johns Hopkins
On the Outrage of Black Mothers: Healing the Past in the Present
Tuesday, Apr 20, 2021, 12:00 - 1:00 pm EST
Ethics For Lunch
The Many Faces of Trust During the Pandemic: Watch the Video
Ethical Challenges of Effective Pain Management in Patients with Severe Cancer Pain and Substance
Use Disorder: Watch the Video

University of Maryland Carey School of Law
The Rothenberg Health Care Law & Policy Speaker Series
Challenges in Equitable Allocation of SARS CoV-2 Vaccine
Professor R. Alta Charo, the Warren P. Knowles Professor of Law and Bioethics at the
University of Wisconsin at Madison.
Watch the recorded presentation here.
The Politics of Public Health Regulation
Joshua M. Sharfstein, Vice Dean for Public Health Practice and Community Engagement and Professor of
the Practice at the Johns Hopkins Bloomberg School of Public Health
Watch the recorded presentation here.
Eradicating Systemic Racism in the Government's Pandemic Response
Professor Ruqaiijah Yearby, Executive Director and Co-Founder of the Institute for Healing Justice and
Equity Center for Health Law Studies and Professor at the Saint Louis University School of Law
Watch the recorded presentation here.
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CALENDAR OF EVENTS (cont.)
Michigan State University Bioethics
Healthcare Artificial Intelligence Needs Patient Data: Who “Owns” the Data About You?
Adam M. Alessio, PhD, Professor, Department of Computational Mathematics, Science, and Engineering; Department of Biomedical Engineering and Radiology; Institute for Quantitative Health Science &
Engineering, Michigan State University.
View Recorded Webinar
Maternity Care Deserts in Rural Michigan
Andrea Wendling, MD, Director of Rural Medicine and Professor of Family Medicine, Michigan State
University College of Human Medicine.
View Recorded Webinar
Is Seeking Information on Social Media Harmful to Your Health?
Anjana Susarla, PhD, Professor of Information Systems, Michigan State University Eli Broad College of
Business.
View Recorded Webinar
Controversies and Complexities in LGBTQ Health Care
Emily Antoon-Walsh, MD, MA, FAAP (she/her), Seattle Children’s Hospital Regional Pediatric
Hospitalist; Clinical Assistant Professor, Department of Pediatrics, University of Washington.
Barry DeCoster, PhD (he/him), Associate Professor of Bioethics and Philosophy, Department of
Population Health Sciences, Albany College of Pharmacy and Health Sciences.
Henry Ng, MD, MPH, FAAP, FACP (he/they), Center for LGBTQ+ Health, Transgender Surgery
and Medicine Program, Cleveland Clinic Foundation.
View Recorded Webinar

Washington State University
"Bioethics Grand Rounds: Health Professional Rights and Obligations During Pandemic"
April 28th, 2021, Noon-1:00pm PST
Matthew Wynia, PhD, MPH & Heidi Malm, PhD
Register Here
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The Law & Health Care Program
Maryland Healthcare Ethics
Committee Network
University of Maryland
Francis King Carey School of Law
500 W. Baltimore Street
Baltimore, MD 21201

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by the Law and
Healthcare Program at the University of Maryland Francis King Carey School of Law. The purpose of MHECN is to facilitate
and enhance ethical reflection in all aspects of decision making in health care settings by supporting and providing informational
and educational resources to ethics committees serving health care institutions in the state of Maryland. The Network attempts to
achieve this goal by:
•

Serving as a resource to ethics committees as they investigate ethical dilemmas within their institution and as they strive to
assist their institution act consistently with its mission statement;

•

Fostering communication and information sharing among Network members;

•

Providing educational programs for ethics committee members, other healthcare providers, and members of the general
public on ethical issues in healthcare; and

•

Conducting research to improve the functioning of ethics committees and ultimately the care of patients in Maryland.

MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from affiliate
members who provide additional financial support.
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